Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Short-term Investments (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) posted Short-term Investments of $167 million for Q2 2026, down 46.4% from $311.28 million a year earlier and down 29.8% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Short-term Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical's Short-term Investments came in at $259 million, down 40.6% from FY2024.

  • Annual Short-term Investments shows a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
  • In prior years, Ultragenyx Pharmaceutical's Short-term Investments was $436 million in FY2024 (+19.9%), $363.63 million in FY2023 (-40.9%), $614.82 million in FY2022 (+42.1%) and $432.61 million in FY2021 (-11.4%).
  • The Q2 2026 figure stands as the lowest quarterly Short-term Investments since Q4 2017.
  • On a year-over-year basis, Short-term Investments has declined in each of the last four quarters, with an average decline of 11.9% over the last eight quarters.
  • The strongest year-over-year quarter for Short-term Investments in the past five years was Q4 2022, with growth of 42.1%; the weakest was Q3 2025, with a decline of 52.7%.
  • According to Business Quant data, Short-term Investments for the three prior quarters was $238 million (Q1 2026), $259 million (Q4 2025) and $222.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 167.00 Mn
Mar 31, 2026 238.00 Mn
Dec 31, 2025 259.00 Mn
Sep 30, 2025 222.74 Mn
Jun 30, 2025 311.28 Mn
Mar 31, 2025 367.39 Mn
Dec 31, 2024 436.00 Mn
Sep 30, 2024 470.99 Mn
Jun 30, 2024 283.13 Mn
Mar 31, 2024 299.83 Mn
Dec 31, 2023 363.63 Mn
Sep 30, 2023 369.52 Mn
Jun 30, 2023 449.92 Mn
Mar 31, 2023 543.59 Mn
Dec 31, 2022 614.82 Mn
Sep 30, 2022 497.02 Mn
Jun 30, 2022 382.93 Mn
Mar 31, 2022 444.33 Mn
Dec 31, 2021 432.61 Mn
Sep 30, 2021 539.58 Mn
API Access

Ultragenyx Pharmaceutical Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=RARE&period=max&api_key=YOUR_API_KEY